Pralatrexate Recruiting Phase 3 Trials for Peripheral T-Cell Lymphoma (PTCL) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT06072131To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL